The Impact of Obstructive Sleep Apnoea in Women With Polycystic Ovary Syndrome.

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

February 13, 2017

Primary Completion Date

May 11, 2018

Study Completion Date

January 1, 2019

Conditions
Polycystic Ovary SyndromeObstructive Sleep Apnea
Interventions
OTHER

To assess risk of OSA

The risk of OSA will be assessed using the Berlin questionnaire and the Epworth Sleepiness Scale (ESS). Women with at high risk of OSA will have home-based sleep studies performed. Study participants will be divided based on the results of the Berlin and ESS questionnaires and sleep studies into two groups: 1) PCOS low risk OSA: women with normal ESS and normal Berlin questionnaire (no sleep studies performed), or women with normal sleep studies; and 2) PCOS OSA: women with OSA proven by sleep studies.

Trial Locations (1)

CV2 2DX

University Hospitals Coventry & Warwickshire NHS Trust, Coventry

All Listed Sponsors
collaborator

University of Warwick

OTHER

lead

University Hospitals Coventry and Warwickshire NHS Trust

OTHER

NCT03065322 - The Impact of Obstructive Sleep Apnoea in Women With Polycystic Ovary Syndrome. | Biotech Hunter | Biotech Hunter